267 related articles for article (PubMed ID: 25127122)
1. Image-based three-dimensional conformal brachytherapy for medically inoperable endometrial carcinoma.
Gill BS; Kim H; Houser C; Olsen A; Kelley J; Edwards RP; Comerci J; Sukumvanich P; Olawaiye AB; Huang M; Courtney-Brooks M; Beriwal S
Brachytherapy; 2014; 13(6):542-7. PubMed ID: 25127122
[TBL] [Abstract][Full Text] [Related]
2. Pilot study in the treatment of endometrial carcinoma with 3D image-based high-dose-rate brachytherapy using modified Heyman packing: clinical experience and dose-volume histogram analysis.
Weitmann HD; Pötter R; Waldhäusl C; Nechvile E; Kirisits C; Knocke TH
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):468-78. PubMed ID: 15890589
[TBL] [Abstract][Full Text] [Related]
3. Image-guided high-dose-rate intracavitary brachytherapy in the treatment of medically inoperable early-stage endometrioid type endometrial adenocarcinoma.
Jordan SE; Micaily I; Hernandez E; Ferriss JS; Miyamoto CT; Li S; Micaily B
Brachytherapy; 2017; 16(6):1144-1151. PubMed ID: 28958736
[TBL] [Abstract][Full Text] [Related]
4. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
[TBL] [Abstract][Full Text] [Related]
5. Dose volume analysis of radiotherapy for inoperable patients with stage I-II endometrial carcinoma.
Ohkubo Y; Kato S; Kiyohara H; Tsuruoka I; Tamaki T; Noda SE; Ohno T; Nakano T
J Radiat Res; 2011; 52(5):666-73. PubMed ID: 21857147
[TBL] [Abstract][Full Text] [Related]
6. Image-guided tandem and cylinder brachytherapy as monotherapy for definitive treatment of inoperable endometrial carcinoma.
Gebhardt B; Gill B; Glaser S; Kim H; Houser C; Kelley J; Sukumvanich P; Edwards R; Comerci J; Olawaiye A; Courtney-Brooks M; Boisen M; Berger J; Beriwal S
Gynecol Oncol; 2017 Nov; 147(2):302-308. PubMed ID: 28923412
[TBL] [Abstract][Full Text] [Related]
7. Toward four-dimensional image-guided adaptive brachytherapy in locally recurrent endometrial cancer.
Fokdal L; Ørtoft G; Hansen ES; Røhl L; Pedersen EM; Tanderup K; Lindegaard JC
Brachytherapy; 2014; 13(6):554-61. PubMed ID: 25056640
[TBL] [Abstract][Full Text] [Related]
8. What is appropriate target delineation for MRI-based brachytherapy for medically inoperable endometrial cancer?
Carpenter DJ; Stephens SJ; Ayala-Peacock DN; Shenker RF; Raffi J; Meltsner SG; Craciunescu O; Chino JP
Brachytherapy; 2023; 22(2):181-187. PubMed ID: 36335036
[TBL] [Abstract][Full Text] [Related]
9. Triple-tandem high-dose-rate brachytherapy for early-stage medically inoperable endometrial cancer: Initial report on acute toxicity and dosimetric comparison to stereotactic body radiation therapy.
Kauffmann G; Wu T; Al-Hallaq H; Hasan Y
Brachytherapy; 2017; 16(1):141-146. PubMed ID: 27866953
[TBL] [Abstract][Full Text] [Related]
10. Targeting the GTV in medically inoperable endometrial cancer using brachytherapy.
Merfeld EC; Kuczmarska-Haas A; Burr AR; Witt JS; Francis DM; Ntambi JN; Desai VK; Huang JY; Miller JR; Lawless MJ; Wallace CR; Anderson BM; Bradley KA
Brachytherapy; 2022; 21(6):792-798. PubMed ID: 36030167
[TBL] [Abstract][Full Text] [Related]
11. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
[TBL] [Abstract][Full Text] [Related]
12. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of High Risk Clinical Target Volume reduction during Brachytherapy and impact on its coverage in patients with inoperable cervical cancer.
Pobijakova M; Scepanovic D; Paluga M; Fekete M; Mardiak J
Neoplasma; 2018 Mar; 65(3):425-430. PubMed ID: 29788726
[TBL] [Abstract][Full Text] [Related]
14. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging response in patients treated with definitive radiation therapy for medically inoperable endometrial cancer-Does it predict treatment response?
Gebhardt BJ; Rangaswamy B; Thomas J; Kelley J; Sukumvanich P; Edwards R; Comerci J; Olawaiye A; Courtney-Brooks M; Boisen M; Berger J; Beriwal S
Brachytherapy; 2019; 18(4):437-444. PubMed ID: 31005602
[TBL] [Abstract][Full Text] [Related]
16. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
17. Exclusive 3D-brachytherapy as a good option for stage-I inoperable endometrial cancer: a retrospective analysis in the gynaecological cancer GEC-ESTRO Working Group.
Rovirosa A; Zhang Y; Chargari C; Cooper R; Bownes P; Wojcieszek P; Stankiewicz M; Hoskin P; Van der Steen-Banasik E; Segedin B; Najjari D; Pötter R; Tanderup K; Van Limbergen E; ;
Clin Transl Oncol; 2022 Feb; 24(2):254-265. PubMed ID: 34272660
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.
Beriwal S; Kim H; Heron DE; Selvaraj R
Technol Cancer Res Treat; 2006 Oct; 5(5):521-7. PubMed ID: 16981795
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of high-dose-rate brachytherapy in the primary treatment of medically inoperable stage I-II endometrial carcinoma.
Niazi TM; Souhami L; Portelance L; Bahoric B; Gilbert L; Stanimir G
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1108-13. PubMed ID: 16099598
[TBL] [Abstract][Full Text] [Related]
20. Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: a comparison of spatial dose distribution within a matched-pair analysis.
Schmid MP; Kirisits C; Nesvacil N; Dimopoulos JC; Berger D; Pötter R
Radiother Oncol; 2011 Sep; 100(3):468-72. PubMed ID: 21924510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
